Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Minerva Surgical, Inc. (UTRS) had Revenue of $11.96M for the most recently reported fiscal quarter, ending 2023-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2023-09-30

Income Statement Financials
Revenue	$11.96M
Net Income	$-7.18M
Cost of Goods Sold	$5.75M
Gross Profit	$6.22M
Operating Expenses	$18.06M
Operating Income	$-6.10M
Non-Operating Income/Expense	$-1.08M
Pre-Tax Income	$-7.18M
Normalized Pre-Tax Income	$-7.18M
Income after Taxes	$-7.17M
Income from Continuous Operations	$-7.17M
Consolidated Net Income/Loss	$-7.17M
Normalized Income after Taxes	$-7.17M
EBIT	$-6.10M
EBITDA	$-4.58M
Weighted-Average Shares Outstanding (Basic)	8.87M
Weighted-Average Shares Outstanding (Diluted)	8.87M
Earnings per Share (EPS) (Basic)	$-0.81
Earnings per Share (EPS) (Diluted)	$-0.81
Balance Sheet Financials
Current Assets	$40.00M
Property, Plant, and Equipment	$5.43M
Long-Term Assets	$32.78M
Total Assets	$72.78M
Current Liabilities	$21.25M
Long-Term Debt	$27.89M
Long-Term Liabilities	$31.28M
Total Liabilities	$52.53M
Common Equity	$20.25M
Tangible Shareholders Equity	$-2.07M
Shareholders Equity	$20.25M
Common Shares Outstanding	8.88M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-23.09M
Cash Flow from Investing Activities	$-0.10M
Cash Flow from Financial Activities	$26.85M
Beginning Cash	$7.81M
End Cash	$11.47M
Increase/Decrease in Cash	$3.66M
Stock-Based Compensation	$3.21M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.88
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.58
Debt to Equity Ratio	1.95
Gross Margin	51.97%
Operating Margin	-50.95%
EBIT Margin	-50.95%
EBITDA Margin	--
Pre-Tax Profit Margin	-59.99%
Profit Margin	-60.02%
Free Cash Flow	$-23.19M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	0.32
Receiveable Turnover	1.58
Days Sales in Receivables	56.93
Return on Equity	-35.42%
Return on Tangible Equity	346.45%
Return on Assets	-9.86%
Return on Investments	-14.90%
Book Value Per Share	$2.28
Free Cash Flow per Share	$-2.61
Operating Cash Flow per Share	$-2.60

Data from Zacks Investment Research, Inc.